InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: PanchoJimenz post# 74650

Thursday, 04/16/2015 9:51:22 AM

Thursday, April 16, 2015 9:51:22 AM

Post# of 80868
the stock is heavily undervalued.....even if Musclepharm had to dilute the stock raising capital at the same terms as the last pipe deal....that should make the stock be worth at least $11.

Thus far, Musclepharm has not needed to do so...so, it must have maintained sales at a satisfactory level.

Remember that Musclepharm's bank got stocks in escrow and remember that the SEC most likely means that stocks granted to executives will be returned to shareholders....so, at least 1 million shares outstanding should be expected to be returned to company if Musclepharm rose capital and closed SEC investigation.

So, the company is not worth $4....but more like $11 considering the revenues that Musclepharm got.